Blue Sky Pharmaceuticals, LLC

SPRING, TX · Founded 2014 · Biotech · Private

Small molecule therapeutics for antibiotics, antivirals, and oncology

Claim this profile

Follows are private to you and power your alerts

Updated · blueskypharmaceuticals.com

Sector
Biotech
Headquarters
SPRING, TX
Founded
2014
Latest Form D
$41K, Nov 2014
Total capital
$41K
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$41K
1 Form D · last Nov 2014
144 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
1 pending · first 2020
Rank in peer group#481 of 1449

Capital timeline

2014FEDERAL ↑EQUITY ↓Cumulative $41K1st Form D$41K
2014FEDERAL ↑EQUITY ↓Cumulative $41K1st Form D$41K

Latest events

  • Private capital raisedForm D · SEC · 1st filing$41K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1449 peers

Line = median

Biotech · Molecule

  • Granted patents#481 · top 33%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Aron TiptonExecutive OfficerNamed in SEC Form D filings
  • Wesley LambardExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 2
  • GrantedSalvinorin DerivativesUSPTOUS 10,556,889
  • PendingSalvinorin DerivativesUSPTOApplication PCTUS2019066524
  • IONTX INC.Similar federal contract value in Biotech · null in contracts
  • MycoMedica Life Sciences, PBCSimilar federal contract value in Biotech · null in contracts
  • Charlesson, LLCSimilar federal contract value in Biotech · null in contracts
  • JUPITER NEUROSCIENCES, INC.Similar federal contract value in Biotech · null in contracts
  • ONCOVIR, INC.Similar federal contract value in Biotech · null in contracts
  • THERATROPHIX, LLCSimilar federal contract value in Biotech · null in contracts

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .